Approximately 34.2 million people in the U.S. have diabetes, and one-fifth of them will experience painful diabetic neuropathy (PDN) symptoms that can significantly worsen their quality of life and overall healthcare costs. HFX for PDN is an alternative to conventional therapies that uses mild electrical pulses designed to disrupt pain signals associated with PDN before they reach the brain. Find out more at www.hfxforpdn.com.

Leave a Reply

Your email address will not be published. Required fields are marked *